Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Neonatal Safety Information Reported to the FDA During Drug Development Studies
HTML
Details
Locations
Year:
2017
Type:
article
Source:
Therapeutic Innovation & Regulatory Science
DOI:
10.1177/2168479017716713
Authors:
Debbie Avant,
Gerri Baer,
Jason Moore,
Panli Zheng,
Alfred Sorbello,
Ron Ariagno,
Lynne Yao,
Gilbert J. Burckart,
Jian Wang
show all 9
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Thomas Jefferson University,
University of North Carolina at Chapel Hill,
Stanford Medicine,
Stanford University
show all 6
Language:
English
Topic:
Pharmaceutical studies and practices
Subfield:
Pediatrics, Perinatology and Child Health
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
National Institutes of Health,
National Institute of General Medical Sciences
Awards:
G3050811832,
Clinical Pharmacology Training Program
OpenAlex ID:
W2727787101
FWCI:
0.896
Cites:
17
Cited by:
8
Related to:
10